DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wang C, Henrik Rasmussen H, Perrow W. et al.
Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial.
Gastroenterology 2014;
146: 15
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.